Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2.

Chavda, Vivek P; Mishra, Toshika; Vuppu, Suneetha

Chavda, Vivek P; Mishra, Toshika; Vuppu, Suneetha.

Afiliación

Chavda VP; Department of Pharmaceutics and Pharmaceutical Technology, LM College of Pharmacy, Ahmedabad 380009, Gujarat, India.
Mishra T; Department of Biotechnology, Science, Innovation, and Society Research Lab. 115, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
Vuppu S; Department of Biotechnology, Science, Innovation, and Society Research Lab. 115, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.

Vaccines (Basel) ; 11(1)2022 Dec 25.

Article en En | MEDLINE | ID: mdl-36679891

Palabras clave

COVID-19; SARS-CoV-2; hybrid; immunological assays; variants of concern

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google